✦ LIBER ✦

Phase III Study of Mitoxantrone Plus Low Dose Prednisone Versus Low Dose Prednisone Alone in Patients With Asymptomatic Hormone Refractory Prostate Cancer

✍ Scribed by BERRY, WILLIAM; DAKHIL, SHAKER; MODIANO, MANUEL; GREGURICH, MARYANN; ASMAR, LINA

Book ID: 122686307
Publisher: Lippincott Williams and Wilkins
Year: 2002
Tongue: English
Weight: 82 KB
Volume: 168
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)64163-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of sequential chemotherap

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer

✍ Galli, L; Fontana, A; Galli, C; Landi, L; Fontana, E; Antonuzzo, A; Andreuccetti 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase II randomised trial of docetaxel (

Phase II randomised trial of docetaxel (D), estramustine (E) and prednisone (P) — Two schedules — versus mitoxantrone (M) and prednisone in patients (PTS) with hormone refractory prostate cancer (HRPC)

✍ S. Qudard; E.B. Banu; E. Voog; H. Hardy-Bessard; C. Linassier; P. Beuzeuboe; A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

PHASE II TRIAL OF TESMILIFENE PLUS MITOX

PHASE II TRIAL OF TESMILIFENE PLUS MITOXANTRONE AND PREDNISONE FOR HORMONE REFRACTORY PROSTATE CANCER: HIGH SUBJECTIVE AND OBJECTIVE RESPONSE IN PATIENTS WITH SYMPTOMATIC METASTASES

✍ RAGHAVAN, D.; BRANDES, L.J.; KLAPP, K.; SNYDER, T.; STYLES, E.; TSAO-WEI, D.; LI 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 87 KB

Phase II Study of Low-Dose Docetaxel/Est

Phase II Study of Low-Dose Docetaxel/Estramustine in Elderly Patients or Patients Aged 18-74 Years with Hormone-Refractory Prostate Cancer

✍ Sreeni Chittoor; William Berry; David Loesch; Keith Logie; John Fleagle; Stephan 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 172 KB

899 PUBLICATION A phase II study of sequ

899 PUBLICATION A phase II study of sequential chemotherapy with docetaxel-estramustine phosphate (DE) followed by mitoxantrone-prednisone (MP) in patients (pts.) with metastatic hormone refractory prostate cancer (MHRPC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

A randomized phase II trial of personali

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

✍ Masanori Noguchi; Tatsuyuki Kakuma; Hirotsugu Uemura; Yasutomo Nasu; Hiromi Kumo 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 422 KB